Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinib. uri icon

Overview

publication date

  • September 27, 2013

Research

keywords

  • ErbB Receptors
  • Inflammatory Breast Neoplasms
  • Mutation
  • Protein Kinase Inhibitors
  • Quinazolines

Identity

Scopus Document Identifier

  • 84892746649

Digital Object Identifier (DOI)

  • 10.1016/j.clbc.2013.09.010

PubMed ID

  • 24201163

Additional Document Info

volume

  • 14

issue

  • 1